Dave's Who 13 by James Loud Genetics: A Comprehensive Strain Guide

Origin and Breeding History

Dave's Who 13 is a mostly sativa cultivar bred by James Loud Genetics, a California-based breeder renowned for rigorous phenotype selection and high-terpene modern hybrids. The strain name hints at a selection-driven project, with the '13' likely signifying a keeper phenotype from a larger hunt rather than a reference to a specific parental cross. In breeder circles, this naming convention is common for lines where the standout expression is identified by a number after a wide seed run. As of 2024, the breeder has not publicly released a definitive parental pedigree for Dave's Who 13.

James Loud Genetics has consistently targeted market-ready chemovars with strong resin production, bright terpene expression, and vigorous growth. Their selections often emphasize sativa-leaning effects that remain functional and creative, a niche increasingly in demand among daytime consumers. This fits the reported experience of Dave's Who 13, which is frequently described by growers as a rapid-onset, mentally lifting cultivar with an energetic push. Early adopter reports highlight its clarity over couchlock, aligning with its mostly sativa heritage.

The project's development likely involved testing across multiple environments to stress-test stability and find the best-performing cut. A phenotype tagged #13 would be chosen for attributes like consistent yield, terpene intensity, and structural resilience. Breeders typically quantify these results through yield per square foot, total terpene percentage, and uniformity of plant height across replicates. While exact internal metrics are not public, the commercial-ready polish of Dave's Who 13 suggests it hit those targets.

Market interest in sativa-dominant varieties has grown as consumers diversify beyond heavy indica-dominant profiles. In several U.S. markets between 2020 and 2023, lab averages for legal flower hovered near 19–22% THC, making high-terp sativas with distinctive flavor profiles more competitive regardless of absolute potency. Dave's Who 13 appears to be positioned precisely for that opportunity space. Its breeder pedigree and traction among connoisseur growers underscore that intent.

Because strains evolve through selections and backcrosses, living genetic lines are more like families than fixed recipes. Dave's Who 13 should be understood as a stabilized selection within that family, not a static chemical formula. This contextual view explains why different grows can present subtly different terpenes or aromas while retaining a recognizable core character. For consumers and cultivators, this history signals a balance of innovation and repeatable performance.

Genetic Lineage and Phenotypic Expectations

The exact parentage of Dave's Who 13 has not been formally published by James Loud Genetics as of the latest information. However, multiple grow logs and sensory notes from cultivators describe traits strongly associated with modern sativa-forward lines. These include a pronounced vertical stretch in early bloom, narrow-to-medium leaf morphology, and a terpene profile that often leans terpinolene, limonene, or pinene. Collectively, these clues point to ancestry that draws from Haze-like or tropical sativa families.

Sativa-dominant hybrids commonly exhibit a 1.5x to 3x stretch upon transition to 12/12 light cycles. Growers who ran Dave's Who 13 in controlled indoor conditions frequently report a 1.8x–2.4x stretch window when flipped at 12–16 inches of height. This trait guides training strategy and canopy management, with earlier topping and low-stress training favored over hard late defoliation. The plant’s internodal spacing is moderate, supporting good light penetration with proper pruning.

Buds typically present as elongated spears rather than compact golf balls, a hallmark of sativa-leaning structure. Calyx-to-leaf ratio is reported as favorable, simplifying trim work and improving bag appeal. Resin heads appear plentiful, with trichome density noted on sugar leaves and calyx tips by week 6–7 of bloom. Sativa-like foxtailing can occur under high PPFD or excessive heat, but this is manageable with environmental tuning.

Chemical expression in sativa-forward lines often favors monoterpenes that volatilize readily and express bright aromas. Observers describe Dave's Who 13 as citrus-herbal with occasional floral or pine lift, suggesting a mix where terpinolene or limonene may lead, with supporting alpha-pinene, beta-pinene, and beta-caryophyllene. Minor terpenes like ocimene and linalool may add nuance, especially in late flower. This structure aligns with a daytime, alert effect profile.

Because phenotype expression can vary by environment, expect some plasticity in aroma and yield across media and schedules. Coco and rockwool systems tend to drive faster growth and denser stacking if EC and VPD are tuned. Organic living soil may enhance terpene complexity at a modest trade-off in raw yield, a common pattern noted across sativa-dominant cultivars. Selecting the cultivation style that fits your goals will make the most of this line.

Botanical Appearance and Structure

Dave's Who 13 grows with medium vigor in vegetative stages, accelerating rapidly once established. Leaflets trend narrow to medium width with serrations that are clean and pronounced. Stems are moderately flexible, making the plant amenable to low-stress training without immediate risk of snapping. Internodes are spaced to allow airflow, which helps prevent moisture-related issues in dense canopies.

During pre-flower and early bloom, expect a pronounced apical drive. Primary colas reach for light, and side branches respond well to topping that redistributes auxin and builds a broader canopy. With a two-top or four-top strategy, plants fill a SCROG evenly in 10–14 days post-flip. This structure supports multiple mid-sized colas instead of a single giant spear, improving uniform ripening.

Flowers form as segmented spears with stacked calyxes that swell late, typically around weeks 7–9 of bloom. Trichome formation is evident by mid-flower, with sugar leaves frosting early and calyx heads swelling toward harvest. Pistil coloration shifts from bright white to amber-orange toward finish, but trichome color is the more reliable ripeness indicator. Fans often fade lime to golden yellow with proper nutrient drawdown.

In optimal conditions, the cultivar exhibits a healthy calyx-to-leaf ratio, easing trimming and improving visual appeal. Foxtailing can appear if canopy temperatures exceed 28–29°C under high PPFD, but mild stacking is not always detrimental and may be largely aesthetic. Stem strength is sufficient for most indoor runs, though late-season stakes or netting are recommended as colas pack on weight. Overall, the plant presents as elegant and orderly when trained early and fed consistently.

Aroma and Terpene Expression

Aroma development in Dave's Who 13 ramps up sharply after week 4 of bloom, intensifying into a complex citrus-herbal bouquet by week 7. Many growers report a dominant note of bright lemon or mixed citrus peel, often underpinned by green pine and fresh herbs. Secondary nuances can include floral lilac, sweet melon, or a faint tropical lift reminiscent of mango skin. On stem rubs, expect sharper pine-solvent facets, which soften into sweeter tones as flowers cure.

If terpinolene is prominent—as is common in many sativa-leaning lines—the nose will read as effervescent and high-tone. Terpinolene blends readily with limonene to suggest citrus soda, with pinene adding forest-clean accents. Beta-caryophyllene can lend a peppery base that stabilizes the bright top notes and improves persistence in the jar. This balance makes the aroma both immediately striking and shelf-stable over a proper cure.

Terpene intensity is sensitive to environmental conditions, especially late-flower heat and post-harvest handling. Total terpene content in high-performing sativa hybrids frequently lands between 1.5% and 3.0% by dry weight, with elite runs measuring above 3.5% under ideal conditions. While specific lab data for Dave's Who 13 are limited, its breeder reputation and grower feedback suggest it can compete in this range. Protecting terpenes during dry and cure is essential to preserve this expression.

Breaking the buds releases layers beyond the initial jar aroma. Some cuts reveal a distinct sweet-citrus hard candy note that sits atop a resinous, piney core. Others shift toward an herbaceous lemon-thyme with a whisper of floral sweetness. These differences reflect phenotypic nuance and grower technique rather than a fundamentally different chemotype.

Flavor and Combustion Character

On inhalation, Dave's Who 13 presents a crisp citrus entry with a clean pine snap, followed by light floral-herbal undertones. Vaporization at 175–190°C accentuates the lemon-lime and green apple-like brightness while preserving volatile monoterpenes. Combustion smoothness improves markedly after a slow cure, with peppery beta-caryophyllene notes emerging on the exhale. The finish tends to be refreshing rather than cloying.

Users often describe the mouthfeel as light to medium-bodied, lacking the heavy resinous coating common to some indica-leaning cultivars. This makes it a pleasant daytime profile, especially in portable vaporizers where flavor detail is most apparent. With joints or bowls, a white-to-light-gray ash indicates a clean mineral balance and thorough cure. Excessively dark ash usually points to rushed drying or residual moisture rather than genetics.

Terpene persistence is above average for a citrus-forward cultivar, holding flavor through multiple pulls. A jar with 58–62% relative humidity packs tends to maintain aromatic stability for 60–90 days if stored in the dark at 15–21°C. Past that window, expect top-note attenuation as monoterpenes volatilize, while spicier sesquiterpenes become more noticeable. Proper storage keeps the flavor closer to harvest quality for longer.

Cannabinoid Profile and Potency

Publicly available certificates of analysis (COAs) specific to Dave's Who 13 are scarce, which is not unusual for boutique or newly released cultivars. Nevertheless, sativa-dominant, modern U.S. genetics commonly test between 18% and 26% THC in regulated markets, with a mean near 20–22% in many statewide datasets from 2021–2023. Early grower and retailer anecdotes place Dave's Who 13 comfortably within this competitive band when properly grown and cured. Potency appears to be driven more by cultivation precision than by an inherent cap.

CBD content in high-THC sativa hybrids is typically negligible, often below 0.5%. Minor cannabinoids, especially CBG, can appear in the 0.2–1.0% range, adding to perceived clarity and focus in the effect profile. Trace THCV has been observed in some sativa families with African lineage, but without lab confirmation it is prudent to consider THCV as a possible trace rather than a defining feature. As lab testing becomes more widespread for this cultivar, a clearer distribution will emerge.

Total cannabinoids—the sum of THC, CBD, CBG, and others—frequently exceed 20% in well-grown modern sativa hybrids. In practical terms, this means a single 0.1 g inhaled dose may deliver 18–26 mg of delta-9 THC equivalency, a level adequate for strong effects in many users. For novice consumers, a 2–5 mg THC starting dose remains the standard harm-minimizing recommendation. Experienced consumers may titrate higher, but daytime clarity remains a core strength of this line when dosed modestly.

It is important to remember that potency statistics do not predict subjective effect quality on their own. Terpene composition modifies perceived intensity, onset speed, and duration; the so-called entourage effect is a useful heuristic in this context. For Dave's Who 13, the bright terpene cluster appears to enhance alertness and mood lift, helping the cultivar feel strong without being sedating. This interplay likely explains its reputation for a clear, productive headspace.

From a cultivation standpoint, environmental factors can move potency by several percentage points. Light intensity, canopy temperature, and nutrient balance—especially adequate nitrogen early and sufficient potassium late—contribute to cannabinoid synthesis. Over-fertilization or heat stress can depress total cannabinoids while degrading terpenes, leading to harsher smoke at the same nominal THC. Precision grows routinely outperform average runs by 10–20% in potency and terpene totals.

Terpene Profile and Minor Compounds

While definitive terpene data for Dave's Who 13 await broader third-party testing, its sensory signature aligns with several common sativa-forward chemotypes. The most likely dominant candidates are terpinolene or limonene, with significant contributions from alpha-pinene, beta-pinene, and beta-caryophyllene. Depending on the phenotype and environment, ocimene, linalool, and humulene may round out the profile. This mix supports a bright, uplifting aroma with a grounded spicy backbone.

In modern legal markets, the median total terpene content for top-shelf flower often falls between 1.5% and 2.5%, with exceptional cultivars surpassing 3.0%. Sativa-leaning cultivars that are terpinolene-dominant have been documented in the 1.3–2.8% total terpene range, with individual terpinolene values frequently 0.4–1.2%. Limonene, when co-dominant, often measures 0.3–0.8%. Pinene totals, split between alpha and beta isomers, commonly sit at 0.2–0.6% combined.

These numbers matter because individual terpenes correlate with perceived effects. Pinene has been associated with alertness and potential short-term memory support, while limonene correlates with elevated mood and perceived stress reduction in survey data. Beta-caryophyllene uniquely binds to CB2 receptors, a property that may underpin anecdotal reports of reduced inflammation-related discomfort. Terpinolene’s association with fresh, effervescent aroma is often linked to creative, mentally energizing sessions.

Minor cannabinoids and sulfur-containing volatiles can also shape the experience. Trace levels of CBG in the 0.2–0.6% range are common in high-THC hybrids and may contribute to mental clarity. Sulfur compounds, if present in tiny amounts, can intensify citrus notes without reading as skunky, adding sparkle to the nose. These micro-components are sensitive to drying conditions and can be lost if temperatures run high.

Growers seeking maximal terpene expression should prioritize stable late-flower temperatures and a slow dry. Keeping post-harvest temperatures near 16°C and relative humidity near 60% for 10–14 days preserves monoterpenes better than rapid drying. Avoiding direct airflow on colas reduces localized desiccation that can mute top notes. These controls can make the difference between a good and a great jar for terpene-rich cultivars like Dave's Who 13.

Experiential Effects and Use Cases

Consumers typically describe Dave's Who 13 as uplifting, clear-headed, and fast-acting. Onset often occurs within 2–5 minutes with inhalation, peaking around 15–25 minutes, and tapering over 90–180 minutes depending on dose and tolerance. The mental effect centers on alertness and positive mood without heavy body sedation. Many report enhanced focus suitable for creative tasks or light social activity.

Physically, the cultivar tends to feel light and mobile, with minimal couchlock at moderate doses. Some users note a gentle, tension-releasing effect in the shoulders and neck, likely tied to the caryophyllene and humulene contributions. Increased heart rate and dry mouth are common cannabis side effects and may be noticed here as well. As with other sativa-dominant profiles, a small subset of users may experience transient edginess if they overshoot their comfortable dose.

Anecdotal use cases include daytime productivity, brainstorming sessions, and pre-exercise motivation for low-intensity activities such as walking or yoga. The strain’s clarity can complement tasks requiring pattern recognition or divergent thinki